Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells
- 19 December 2002
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 15 (3) , 327-338
- https://doi.org/10.1016/s0898-6568(02)00124-9
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- RHO–GTPases and cancerNature Reviews Cancer, 2002
- Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol loweringThe American Journal of Cardiology, 2000
- Regulation of Urokinase Receptor Transcription by Ras- and Rho-Family GTPasesBiochemical and Biophysical Research Communications, 2000
- Rho-Kinase Inhibitor Retards Migration and in Vivo Dissemination of Human Prostate Cancer CellsBiochemical and Biophysical Research Communications, 2000
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Regulation of the mevalonate pathwayNature, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970